Doctor profile · Federal record
Dr. ABDHISH BHAVSAR, M.D.
Retina Specialist (Ophthalmology) Physician (CMS: OPHTHALMOLOGY) · Retina Specialist (Ophthalmology) Physician · Retina Specialist (Ophthalmology) Physician · MINNEAPOLIS, MN
- NPI 1396776951
- Accepts Medicare
- MIPS 99.4 / 100 · 2023
- 35 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
710 E 24TH ST STE 304
MINNEAPOLIS, MN 554043846
(612) 871-2292
fax (952) 460-5274 - Mailing address
-
710 E 24TH ST, SUITE 304
MINNEAPOLIS, MN 554043846
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- September 29, 2020
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State licenses (3)
- Minnesota #39922 · Illinois #036096763 · California #G81049
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396776951. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
14,088
Distinct HCPCS
10
Medicare allowed
$2,998,877
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 4,435 | 213 | $273 | |
92134 |
Imaging of retina | 2,863 | 951 | $40 | |
67028 |
Injection of drug into eye | 1,539 | 312 | $125 | |
92012 |
Established patient problem focused exam of visual system | 1,355 | 488 | $91 | |
J0178 |
Injection, aflibercept, 1 mg | 1,030 | 104 | $867 | |
92014 |
Established patient complete exam of visual system | 741 | 552 | $128 | |
J3590 |
Unclassified biologics | 559 | 96 | $275 | |
92020 |
Exam of the internal drainage system of eye | 225 | 72 | $28 | |
76512 |
2d ultrasound scan of eye tissue and structures | 224 | 145 | $52 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 221 | 22 | $230 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 618. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$7,628
Transactions
2
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ocular Therapeutix, Inc. | 2 | $7,627.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
562
Patients
324
Total drug cost
$28,390
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 235 | 166 | $14,198 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 103 | 50 | $3,250 |
| Brimonidine Tartrate | Generic | 61 | 26 | $1,166 |
| Ketorolac Tromethamine | Generic | 45 | 18 | $1,902 |
| Timolol Maleate | Generic | 41 | 23 | $635 |
| Atropine Sulfate | Generic | 28 | 24 | $1,001 |
| Latanoprost | Generic | 19 | 0 | $469 |
| Cyclopentolate Hcl | Generic | 17 | 17 | $236 |
| Rhopressa (Netarsudil Mesylate) | Brand | 13 | 0 | $5,534 |